[18F]PSMA-1007 PET Improves the Diagnosis of Local Recurrence and Lymph Node Metastases in a Prostate Cancer Patient With a History of Bilateral Hip Arthroplasty-Reference-Cited by-同舟云学术

[18F]PSMA-1007 PET Improves the Diagnosis of Local Recurrence and Lymph Node Metastases in a Prostate Cancer Patient With a History of Bilateral Hip Arthroplasty

Published:2018-04 Issue:2 Volume:16 Page:111-113
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Giesel Frederik L.,Will Leon,Paddubny Kiryl,Kremer Christophe,Rathke Hendrik,Radtke Jan P.,Kopka Klaus,Haufe Sabine,Haberkorn Uwe,Kratochwil Clemens

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference16 articles.

1. Diagnostic efficacy of (68)gallium-PSMA positron emission tomography compared to conventional imaging for lymph node staging of 130 consecutive patients with intermediate to high risk prostate cancer;Maurer;J Urol,2016

2. Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients;Afshar-Oromieh;Eur J Nucl Med Mol Imaging,2017

3. [68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH;Afshar-Oromieh;Eur J Nucl Med Mol Imaging,2012

4. Local recurrence of prostate cancer after radical prostatectomy is at risk to be missed in 68Ga-PSMA-11-PET of PET/CT and PET/MRI: comparison with mpMRI integrated in simultaneous PET/MRI;Freitag;Eur J Nucl Med Mol Imaging,2017

5. Preclinical evaluation of 18F-PSMA-1007, a new prostate-specific membrane antigen ligand for prostate cancer imaging;Cardinale;J Nucl Med,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of PSMA-ligands imaging in Renal Cell Carcinoma management: current status and future perspectives;Journal of Cancer Research and Clinical Oncology;2022-02-25

2. Utility of 18F–Prostate-Specific Membrane Antigen 1007 in Imaging of Tumor Thrombus of Renal Cell Carcinoma;Clinical Nuclear Medicine;2021-04-20

3. Development of PSMA-1007-Related Series of 18F-Labeled Glu-Ureido-Type PSMA Inhibitors;Journal of Medicinal Chemistry;2020-08-27

4. Theranostics for Advanced Prostate Cancer: Current Indications and Future Developments;European Urology Oncology;2019-03